Association of dipeptidyl peptidase‐4 inhibitor use and risk of pancreatic cancer in individuals with diabetes in Japan

Sodai Kubota,Takuya Haraguchi,Hitoshi Kuwata,Yusuke Seino,Kenta Murotani, Takumi Tajima, Gen Terashima, Makiko Kaneko,Yoshihiro Takahashi,Ken Takao,Takehiro Kato,Kenichiro Shide,Saeko Imai,Atsushi Suzuki,Yasuo Terauchi,Yuichiro Yamada,Yutaka Seino,Daisuke Yabe

Journal of Diabetes Investigation（2022）

引用 2|浏览9

暂无评分

摘要

This database study shows that there is not a significant PC risk due to DPP-4i treatment in individuals with diabetes in Japan, but larger studies with longer follow up are required to confirm these findings.

查看译文

关键词

Claims database,Dipeptidyl peptidase-4 inhibitor,Pancreatic cancer

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要